USF

TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

Retrieved on: 
Thursday, April 18, 2024
American Academy, University, Participation, MD, Research, Publication, Patient, RMS, AAN, USF, Sclerosis, Multiple sclerosis, Poster, Therapy, Pharmaceutical industry

NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado.

Key Points: 
  • NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado.
  • Links to the data presented yesterday are included below.
  • Michael S. Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated “The data presented this week during the AAN annual meeting emphasizes our commitment to research and the multiple sclerosis community.
  • We look forward to continuing to evaluate date from the ULTIMATE Phase 3 trials and presenting additional exploratory data throughout the year.”
    Link to Poster Presentation: Ublituximab Significantly Reduces Radiological Disease Activity at 12 Weeks: Post-hoc analysis of Participants with Highly Active Disease in the ULTIMATE I & II Phase 3 Studies
    Lead Author: Derrick Robertson, MD - University of South Florida (USF) Morsani College of Medicine in Tampa, Florida
    Lead Author: Derrick Robertson, MD - University of South Florida (USF) Morsani College of Medicine in Tampa, Florida
    All data presented at AAN is also available on the Publications page, located within the Pipeline section, of the Company’s website at www.tgtherapeutics.com/publications.cfm .

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

Retrieved on: 
Monday, April 15, 2024
American Academy, University, Participation, MD, Publication, Patient, RMS, AAN, USF, Mount Sinai Hospital, Multiple sclerosis, Therapy, Pharmaceutical industry

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado.

Key Points: 
  • NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado.
  • A link to the data presented yesterday is included below.
  • Two additional presentations will be shared on Wednesday April 17, 2024.
  • Michael S. Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated “The ULTIMATE I & II Phase 3 trials demonstrated robust clinical activity for BRIUMVI compared to teriflunomide and these post-hoc analyses provide interesting new insights and support BRIUMVI’s utility as an important treatment option for patients with relapsing forms of multiple sclerosis.

Tampa General Hospital to Establish Dr. Jagadamba and Krishna Chivukula Men's Center with $6.5 Million Gift from Family

Retrieved on: 
Wednesday, April 10, 2024
Tampa General Hospital, Health, Male, Partnership, Injection molding machine, TGH, Patient, USF, Nursing

TAMPA, Fla., April 10, 2024 /PRNewswire/ -- Tampa General Hospital (TGH) revealed plans this week for a new center focused on men's health made possible with the generous contribution of Dr. Jagadamba and Krishna Chivukula to the TGH Foundation.

Key Points: 
  • TAMPA, Fla., April 10, 2024 /PRNewswire/ -- Tampa General Hospital (TGH) revealed plans this week for a new center focused on men's health made possible with the generous contribution of Dr. Jagadamba and Krishna Chivukula to the TGH Foundation.
  • The Dr. Jagadamba and Krishna Chivukula Men's Health Center will provide seamless, coordinated, comprehensive primary and preventive care for male patients, just as the Muma Center focuses on women's health.
  • Construction on the Dr. Jagadamba and Krishna Chivukula Men's Health Center is expected to begin in the next couple of months, with plans to open in 2025.
  • "We are extremely honored to partner with the Chivukula family as they make their first gift to Tampa General.

WatchGuard Threat Lab Analysis Shows Surge in Evasive Malware Supercharging an Already Powerful Threat Wave

Retrieved on: 
Wednesday, March 27, 2024
Maas, Organization, PowerShell, TLS, Prevalence, Intelligence, WatchGuard, Research, Software, Trojan, USF

The average malware detections per Firebox rose 80% from the previous quarter, illustrating a substantial volume of malware threats arriving at the network perimeter.

Key Points: 
  • The average malware detections per Firebox rose 80% from the previous quarter, illustrating a substantial volume of malware threats arriving at the network perimeter.
  • Zero-day malware detections jumped to 60% of all malware detections, up from 22% the previous quarter.
  • However, zero-day malware detections with TLS fell to 61%, which was a 10% decrease from Q3, showing the unpredictability of malware in the wild.
  • Both variants redirect users to malicious links, and both malware loaders attempt to load DarkGate malware on the victim’s computer.

CES Power Announces Partnership Extension with James Roe for 2024 INDY NXT by Firestone Season

Retrieved on: 
Tuesday, March 26, 2024
Firestone, Temperature, Roe, Wi-Fi, Partnership, Andretti Autosport, NXT, Formula Ford, CCTV, NTT, USF, European, Renewable energy

MEMPHIS, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- CES Power, the leading global provider of cutting-edge power generation, distribution, and temperature control equipment, and Irish race car driver James Roe today announced the extension of their partnership for the 2024 INDY NXT™ by Firestone championship season.

Key Points: 
  • MEMPHIS, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- CES Power, the leading global provider of cutting-edge power generation, distribution, and temperature control equipment, and Irish race car driver James Roe today announced the extension of their partnership for the 2024 INDY NXT™ by Firestone championship season.
  • 29 Topcon Dallara entry of Andretti Global this season in the INDY NXT by Firestone championship, the official development series for the NTT INDYCAR SERIES.
  • “Our renewed partnership with James Roe and the launch of CES Global and CES Technologies represents our commitment to innovation, sustainability, and global growth.
  • The 2024 INDY NXT by Firestone season kicked off on March 10 with Roe featuring the CES Power logo on the sleeves of his race suit and on the front wing of his Andretti Global machine.

California Supreme Court Justice Martin J. Jenkins ’77 to Address Santa Clara University Class of 2024

Retrieved on: 
Monday, April 8, 2024
Professional Services, Education, White House, Federal Government, Public Policy, Government, State, Local, Legal, University, Alameda County Superior Court, Associate, Character, Public policy, Ethics, History, Justice, Supreme court, Santa Clara University, USF, Justice Jenkins, Private law, Family, Supreme Court of California, School

Martin J. Jenkins ’77, California Supreme Court Associate Justice and former Judicial Appointments Secretary to California Gov.

Key Points: 
  • Martin J. Jenkins ’77, California Supreme Court Associate Justice and former Judicial Appointments Secretary to California Gov.
  • Gavin Newsom ’89, will be the keynote speaker at Santa Clara University’s 173rd commencement ceremony on June 15.
  • Justice Jenkins was confirmed as an Associate Justice of the California Supreme Court on November 10, 2020.
  • “I look forward to celebrating commencement with Santa Clara University’s Class of 2024,” said Jenkins.

University of South Florida plans to launch college focused on artificial intelligence, cybersecurity and computing

Retrieved on: 
Thursday, March 21, 2024
Rhea, Research, Health, Organization, Growth, University of South Florida, National Science Foundation, Humanities, University, Trustee, Artificial intelligence, Faculty, Student, USF, Government, Engineering, Management

TAMPA, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- The University of South Florida announced today its intention to create a college focused on the rapidly evolving fields of artificial intelligence (AI), cybersecurity and computing, with the goal of positioning the Tampa Bay region and state of Florida as a national leader.

Key Points: 
  • TAMPA, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- The University of South Florida announced today its intention to create a college focused on the rapidly evolving fields of artificial intelligence (AI), cybersecurity and computing, with the goal of positioning the Tampa Bay region and state of Florida as a national leader.
  • USF is the first university in Florida and among the first in the nation to announce plans to create a college dedicated to AI and cybersecurity.
  • The creation of a new college would leverage USF's existing strengths and partnerships in AI, cybersecurity and computing, as well as its location in the Tampa Bay region, a hub for technology and defense industries.
  • At USF, there are approximately 200 faculty members currently engaged in research in related disciplines, which are seeing significant growth in funding awards.

University of South Florida research funding reaches record high of $692 million

Retrieved on: 
Wednesday, March 20, 2024
Rhea, College, Health, Corps, Brain, Organization, Growth, Alzheimer's disease, National Science Foundation, University, Insomnia, Knowledge, Research, Sleep, Bird, Engineer, Chronic pain, AAAS, NIH, Water, USF, Bangladesh Technical Education Board, Spectrum, Disorder

“The University of South Florida's record-breaking success in research funding is a reflection of our commitment to advancing new knowledge, fostering innovation and making a positive impact on society," USF President Rhea Law said.

Key Points: 
  • “The University of South Florida's record-breaking success in research funding is a reflection of our commitment to advancing new knowledge, fostering innovation and making a positive impact on society," USF President Rhea Law said.
  • "The dedicated work of our world-class faculty, talented research staff and collaborative partners continues to lift USF’s research enterprise to new heights."
  • USF’s funding from private partnerships grew by 11% to $218 million, while funding from state and local sources nearly doubled to $82 million.
  • “This substantial increase in research enterprise funding reflects USF’s stature as a top public research university,” said Sylvia Wilson Thomas, USF vice president for research and innovation.

Tampa General Hospital's Dr. Peggy Duggan Named a Tampa Bay BusinessWoman of the Year

Retrieved on: 
Tuesday, April 2, 2024
Tampa General Hospital, Culture, Growth, EVP, Bed, Infection, Caregiver, Partnership, TGH, Patient, American City Business Journals, Hospital, Businessperson, Safety, USF, Patient safety, ICU, Physician, Health, Nursing

TAMPA, Fla., April 2, 2024 /PRNewswire/ -- Dr. Peggy Duggan, executive vice president, chief physician executive and chief medical officer of Tampa General Hospital (TGH), was one of just 30 leaders honored by the Tampa Bay Business Journal as a 2024 BusinessWoman of the Year. This award program annually recognizes some of the most dynamic and influential businesswomen in the Tampa Bay region, highlighting their collective positive impact on the community, and honorees were celebrated at a gala event at the JW Marriott Tampa Water Street on March 29.

Key Points: 
  • TAMPA, Fla., April 2, 2024 /PRNewswire/ -- Dr. Peggy Duggan, executive vice president, chief physician executive and chief medical officer of Tampa General Hospital (TGH), was one of just 30 leaders honored by the Tampa Bay Business Journal as a 2024 BusinessWoman of the Year.
  • "Peggy is an outstanding leader and an exceptional colleague whose impact within our organization and in our community cannot be understated," said John Couris, president and CEO of Tampa General Hospital.
  • At Tampa General, Duggan oversees all functions related to physicians and patient care, quality, safety and patient experience for the academic and research health system.
  • Duggan and the list of 2024 BusinessWoman of the Year honorees are profiled in the print edition of the Tampa Bay Business Journal, as well as online here .

Silicon Valley Venture Capitalists' Confidence Inches Higher in the 4th Quarter of 2023, According to University of San Francisco Research Study in its 20th Year

Retrieved on: 
Thursday, March 21, 2024
Pillar, Vision Capital, Uncertainty, Satellite, Growth, Environment, Intelligence, SAN, Diffusion, Research, Acquisition, Entrepreneurship, University, AI, Institutional Venture Partners, Silicon, Icon Ventures, Iron pillar, USF, Initial public offering, Research report, University of San Francisco, School

SAN FRANCISCO, March 21, 2024 /PRNewswire-PRWeb/ -- The Silicon Valley Venture Capitalist Confidence Index™ for the fourth quarter of 2023, based on a January 2024 survey of 32 San Francisco Bay Area venture capitalists, registered 3.63 on a 5-point scale (with 5 indicating high confidence and 1 indicating low confidence). The Q4 2023 Index inched higher from the prior quarter's reading of 3.57 and now hovers just below the 20-year average of 3.65.

Key Points: 
  • SAN FRANCISCO, March 21, 2024 /PRNewswire-PRWeb/ -- The Silicon Valley Venture Capitalist Confidence Index™ for the fourth quarter of 2023, based on a January 2024 survey of 32 San Francisco Bay Area venture capitalists, registered 3.63 on a 5-point scale (with 5 indicating high confidence and 1 indicating low confidence).
  • The Q4 2023 Index inched higher from the prior quarter's reading of 3.57 and now hovers just below the 20-year average of 3.65.
  • It aims to provide unique quantitative and qualitative trend data and analysis on the confidence of Silicon Valley venture capitalists in the future high-growth entrepreneurial environment.
  • Mark Cannice, professor of entrepreneurship and innovation with the USF School of Management, authors the research study each quarter.